CELU Celularity Inc

Nasdaq celularity.com


$ 2.27 $ 0.23 (11.27 %)    

Tuesday, 14-Oct-2025 16:07:00 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 2.27
$ 2.01
$ 1.90 x 10
$ 2.43 x 5
$ 2.01 - $ 2.35
$ 1.00 - $ 5.22
1,707,931
na
60.59M
$ 1.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-29-2025 06-30-2025 10-Q
2 08-29-2025 03-31-2025 10-Q
3 05-08-2025 12-31-2024 10-K
4 12-06-2024 09-30-2024 10-Q
5 11-06-2024 06-30-2024 10-Q
6 10-16-2024 03-31-2024 10-Q
7 07-30-2024 12-31-2023 10-K
8 01-03-2024 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-22-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-19-2021 06-30-2021 10-Q
18 05-24-2021 03-31-2021 10-Q
19 03-04-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-24-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 celularity-announces-publication-of-its-phase-2-study-on-pda-002-demonstrating-safety-and-efficacy-in-treating-complex-diabetic-wounds

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company addressing age-related and d...

Core News & Articles

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

 wbb-securities-upgrades-celularity-to-buy-maintains-price-target-to-6

WBB Securities analyst Steve Brozak upgrades Celularity (NASDAQ:CELU) from Hold to Buy and maintains the price target from $...

 wbb-securities-initiates-coverage-on-celularity-with-speculative-buy-rating-announces-price-target-of-6

WBB Securities analyst Steve Brozak initiates coverage on Celularity (NASDAQ:CELU) with a Speculative Buy rating and announc...

 celularity-inc-surges-over-8-pre-market-amid-florida-stem-cell-policy-new-partnership-boost

Celularity Inc. (NASDAQ: CELU) saw an 8.04% rise in stock value during pre-market hours on Tuesday due to a regulatory change.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION